Reagents and instruments for immunology, cell biology and molecular biology.
 
> TCEP HCl [51805-45-9]

TCEP HCl [51805-45-9]

Print Print
Please log in

Cat# orb1300086-1g

Size : 1g

Brand : Biorbyt


TCEP HCl

SKU: orb1300086

Description

TCEP hydrochloride is a water-soluble, non-thiol reducing agent that selectively reduces disulfide bonds to prevent proteolysis. It is widely used in biochemistry and molecular biology for in vitro applications, such as stabilizing proteins and promoting transcription factor-DNA interactions like NF-κB binding.

Images & Validation

−
TCEP HCl

Key Properties

−
CAS Number51805-45-9
MW286.7
Purity>99%
FormulaC9H15O6P HCl
SMILESCl.OC(=O)CCP(CCC(O)=O)CCC(O)=O
TargetOthers
SolubilitySoluble in Water (up to 50 mg/ml)

Bioactivity

−
Target IC50
A549 cells:> 50 μM (GI50)|NS3/4A:12.8 μM|MCF-7 cells:> 50 μM (GI50)|WI-38 cells:> 50 μM (GI50)
In Vivo
METHODS: To investigate the neurotoxicity and its mechanism in mice, TCEP hydrochloride (10-100 mg/kg) was administered by gavage to Kunming mice once a day for 30 days. RESULTS: Compared with the control group, the high dose TCEP group showed a significant decrease in water intake and a significant increase in liver and spleen organ indices. In the water maze test, the escape latency of TCEP-exposed mice was longer than that of the control group, and the total swimming course of the high-dose TCEP group was higher than that of the control group, and the swimming time of the target quadrant was significantly shorter.TCEP exposure may cause neurotoxicity by increasing thyroid hormones and inducing oxidative damage in mice.
In Vitro
METHODS: Human hepatocellular carcinoma cells HepG2 were treated with TCEP hydrochloride (100-400 µM) for 3 days, and cell viability was detected by MTT assay. RESULTS: The viability of HepG2 was significantly reduced to 25.68% and 70.92% after treatment with 200 and 400 µM TCEP for 3 days, whereas the lowest concentration of TCEP (100 µM) did not significantly reduce the viability of HepG2 (3.44%). METHODS: Human peripheral blood mononuclear cell PBMCs were treated with TCEP hydrochloride (0.5-1 mM) for 24 h. Morphological and necrotic changes were assessed by Hoechst 33342/PI staining. RESULTS: Necrosis was observed in cells treated with 0.5 mM of TCEP.

Storage & Handling

−
Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

−
Inhibitor, inhibit, Tris(2-?carboxyethyl)?phosphine, Tris(2-carboxyethyl)phosphine Hydrochloride, Tris(2-carboxyethyl)phosphine hydrochloride, TCEP HCl, TCEP hydrochloride, TCEP Hydrochloride, TCEP
−
  • TCEP HCl

    TCEP HCl [orb1222127]

    >98% (HPLC)

    51805-45-9

    286.65

    C9H16ClO6P

    100 mg, 500 mg, 1 g

Compound Identifiers

PubChem CID
2734570 ↗

Key Properties

−
No computed properties available.

Protocol Information